Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma

Molecular Oncology

Volumn 5, Issue 5, 2011, Pages 465-474

  Teng, Brian L ^a   Hacker, Kathryn E ^b   Chen, Shufen ^b   Means, Anthony R ^a   Rathmell, W Kimryn ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Conditional tumor suppressor; Pin1; Prolyl isomerase; Renal cell carcinoma

Indexed keywords

MESSENGER RNA; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CHROMOSOME 19P; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANS ISOMER; TUMOR GROWTH;

EID: 80053130472     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.06.002     Document Type: Article

References (33)

1. Adam S.J., Counter C.M. A method to generate genetically defined tumors in pigs. Methods Enzymol. 2008, 39-51. Elsevier.
2. Atchison F.W., Capel B., Means A.R. Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development 2003, 130:3579-3586.
3. Ayala G., Wang D., Wulf G., Frolov A., Li R., Sowadski J., Wheeler T.M., Lu K.P., Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 2003, 63:6244-6251.
4. Bao L., Kimzey A., Sauter G., Sowadski J.M., Lu K.P., Wang D.G. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164:1727-1737.
5. Berger M., Stahl N., Del Sal G., Haupt Y. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol. Cell Biol. 2005, 25:5380-5388.
6. Brannon A.R., Reddy A., Seiler M., Arreola A., Moore D.T., Pruthi R.S., Wallen E.M., Nielsen M.E., Liu H., Nathanson K.L. Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns. Genes Cancer 2010, 1:152-163.
7. Chen S., Sanford C.A., Sun J., Choi V., Van Dyke T., Samulski R.J., Rathmell W.K. VHL and PTEN loss coordinate to promote mouse liver vascular lesions. Angiogenesis 2010, 13:59-69.
8. Dalgliesh G.L., Furge K., Greenman C., Chen L., Bignell G., Butler A., Davies H., Edkins S., Hardy C., Latimer C. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010, 463:360-363.
9. Fujimori F., Takahashi K., Uchida C., Uchida T. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G0 arrest. Biochem. Biophys. Res. Commun. 1999, 265:658-663.
10. Gurova K.V., Hill J.E., Razorenova O.V., Chumakov P.M., Gudkov A.V. p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res. 2004, 64:1951-1958.
11. Heimdal K., Lothe R.A., Lystad S., Holm R., Fosså S.D., Børresen A.L. No germline TP53 mutations detected in familial and bilateral testicular cancer. Genes Chromosom. Cancer 1993, 6:92-97.
12. Liou Y.C., Ryo A., Huang H.K., Lu P.J., Bronson R., Fujimori F., Uchida T., Hunter T., Lu K.P. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. 2002, 99:1335-1340.
13. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:904-916.
14. Lu P.J., Zhou X.Z., Shen M., Lu K.P. Function of WW domains as phosphoserine-or phosphothreonine-binding modules. Science 1999, 283:1325-1328.
15. Mantovani F., Tocco F., Girardini J., Smith P., Gasco M., Lu X., Crook T., Del Sal G. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat. Struct. Mol. Biol. 2007, 14:912-920.
16. Massagué J. TGFbeta in cancer. Cell 2008, 134:215-230.
17. Mazelin L., Bernet A., Bonod-Bidaud C., Pays L., Arnaud S., Gespach C., Bredesen D.E., Scoazec J.Y., Mehlen P. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 2004, 431:80-84.
18. O'Connor P.M., Jackman J., Bae I., Myers T.G., Fan S., Mutoh M., Scudiero D.A., Monks A., Sausville E.A., Weinstein J.N. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 1997, 57:4285-4300.
19. O'Hayer K.M., Counter C.M. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. Methods Enzymol. 2006, 637-647. Elsevier.
20. Pang R., Yuen J., Yuen M.F., Lai C.L., Lee T.K.W., Man K., Poon R.T.P., Fan S.T., Wong C.M., Ng I.O.L. PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 2004, 23:4182-4186.
21. Ryo A., Nakamura M., Wulf G., Liou Y.C., Lu K.P. Pin1 regulates turnover and subcellular localization of -catenin by inhibiting its interaction with APC. Nat. Cell Biol. 2001, 3:793-801.
22. Tuominen V.J., Ruotoistenmäki S., Viitanen A., Jumppanen M., Isola J. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res. 2010, 12:R56.
23. Warburton H.E., Brady M., Vlatkovi N., Linehan W.M., Parsons K., Boyd M.T. p53 regulation and function in renal cell carcinoma. Cancer Res. 2005, 65:6498-6503.
24. Winkler K.E., Swenson K.I., Kornbluth S., Means A.R. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 2000, 287:1644-1647.
25. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., Lu K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001, 20:3459-3472.
26. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
27. Yeh E.S., Means A.R. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 2007, 7:381-388.
28. Yeh E., Cunningham M., Arnold H., Chasse D., Monteith T., Ivaldi G., Hahn W.C., Stukenberg P.T., Shenolikar S., Uchida T. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 2004, 6:308-318.
29. Yeh E.S., Lew B.O., Means A.R. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J. Biol. Chem. 2006, 281:241-251.
30. Yi P., Wu R.C., Sandquist J., Wong J., Tsai S.Y., Tsai M.J., Means A.R., O'Malley B.W. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol. Cell Biol. 2005, 25:9687-9699.
31. You H., Zheng H., Murray S.A., Yu Q., Uchida T., Fan D., Xiao Z.X.J. IGF 1 induces Pin1 expression in promoting cell cycle S phase entry. J. Cell Biochem. 2002, 84:211-216.
32. Zacchi P., Gostissa M., Uchida T., Salvagno C., Avolio F., Volinia S., Ronai Z., Blandino G., Schneider C., Del Sal G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419:853-857.
33. Zheng H., You H., Zhou X.Z., Murray S.A., Uchida T., Wulf G., Gu L., Tang X., Lu K.P., Xiao Z.X.J. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419:849-853.